Standout Papers

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase I... 2012 2026 2016 2021 959
  1. Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen (2012)
    Eric Van Cutsem, Josep Tabernero et al. Journal of Clinical Oncology

Immediate Impact

6 from Science/Nature 95 standout
Sub-graph 1 of 17

Citing Papers

Colorectal cancer
2024 Standout
A systems view of the vascular endothelium in health and disease
2024 Standout
1 intermediate paper

Works of Alexia Tellier being referenced

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
2012 Standout

Author Peers

Author Last Decade Papers Cites
Alexia Tellier 847 73 221 382 281 4 1.0k
R Castan 808 31 197 380 284 6 1.0k
Joe McKendrick 845 33 216 407 288 9 1.1k
Yousif Abubakr 1068 47 116 480 330 7 1.2k
Tarek Chidiac 783 41 202 378 184 16 985
E.U. Steinhauer 835 88 111 353 194 10 949
Yu-Chien Chou 476 47 434 406 237 5 1.1k
Seta Shahin 794 49 120 315 183 13 925
B. Nelson 774 44 285 274 196 11 1000
Wei Yu 439 63 307 591 309 10 919
M. Rother 1259 58 133 565 363 8 1.4k

All Works

Loading papers...

Rankless by CCL
2026